Skip to main content
. 2018 Feb 21;36(9):1220–1226. doi: 10.1016/j.vaccine.2018.01.006

Table 1.

Baseline characteristics: Intention-to-treat population.#

Characteristic* DSJI (n = 170) N-S (n = 170)
Age (months)
Mean (SD) 16.4 (1.1) 16.3 (1.1)



Height (cm)
Mean (SD) 77.5 (3.3) 77.9 (2.7)



Weight (kg)
Mean (SD) 9.5 (1.2) 9.4 (1.1)



Gender^
Male, n (%) 97 (57.1%) 77 (45.3%)
Female, n (%) 73 (42.9%) 93 (54.7%)
#

The intention-to-treat population is all participants who received the study vaccine.

*

All subjects were of Indian ethnicity.

^

Numbers of males and females in the study groups were significantly different (p = .039, Fisher’s exact test).